Articles tagged with Organ Transplantation
Scientists at the University of Birmingham have developed a method to coat Hepatic Progenitor Cells (HPCs) with natural sugars, making them stickier and increasing their ability to repair liver tissues. The coating does not harm the cells or stop them from working properly.
A new study from the University of Cincinnati College of Medicine examines pregnancy outcomes in women with kidney transplants who use assisted reproductive technology. The research found increased rates of hypertension and preterm birth, but no significant difference in live birth rates or two-year kidney transplant survival.
Researchers at Mayo Clinic developed pioneering therapies to prevent organ rejection without the need for immunosuppression. A recent phase 3 clinical trial found that 75% of participants were able to stop taking immunosuppressive medications for more than two years, with some patients staying off medication for over three years.
A new study reveals persistent inequalities in children's access to life-saving kidney transplants across the UK. Early disparities in ethnicity, socioeconomic status, and gender persist even after being placed on the waitlist.
Scientists from Pusan National University discovered a genetic biomarker, FCGBP, that is strongly linked to bronchiolitis obliterans syndrome and poor outcomes following lung transplantation. The finding may help identify high-risk patients and devise timely immunosuppressive treatments.
A national survey of 1,000 American adults found that stress (43%) and lack of sleep (39%) are major contributors to a short attention span. The study also identified digital devices as a significant factor, with 35% of respondents citing it as a contributing factor.
A pioneering study has provided unprecedented insights into the immune response following pig-to-human kidney xenotransplantation. Researchers mapped how human immune cells interact with pig kidney tissue, revealing critical early markers of rejection and potential intervention strategies.
A team of international scientists successfully 3D printed functional human islets using a novel bioink, paving the way for more effective and less invasive treatment options. The bioprinted constructs maintained their structure without clumping or breaking down and showed promising results in laboratory tests.
The Mayo Clinic in Arizona has launched a new lung transplant program, providing patients with end-stage lung disease a second chance at life. The program offers world-class care to critically ill patients battling respiratory diseases such as COPD, and is supported by clinical innovation from across Mayo Clinic.
Surgeons at Mount Sinai performed the world's first heart-liver-kidney triple organ transplants in New York State, with two patients making full recoveries after the surgeries. The procedures were led by Anelechi Anyanwu and Sander S. Florman and represent a significant milestone in complex organ transplantation.
Researchers identified a biological process causing donor heart damage during cold storage and found that a drug can prevent this damage. Treatment with the drug nearly tripled pumping strength in human donor hearts, improving blood flow and reducing cell injury.
A new molecular process discovered by researchers contributes to the failure of donor hearts after transplant, but a therapy using medication for high blood pressure has been found to reduce damage. The treatment significantly improves the function of donor hearts and increases their distance in cold storage.
Surgeons from USC and UCLA have successfully performed the world's first-in-human bladder transplant, offering a new treatment option for patients with terminal bladders. The procedure, which combined kidney and bladder transplants, showed promising results in improving the patient's condition and eliminating the need for dialysis.
Surgeons from UCLA Health and Keck Medicine of USC successfully performed the world's first-in-human bladder transplant. The patient, who had lost most of his bladder due to a tumor removal, received a new kidney and bladder through the pioneering technique developed by Drs. Nima Nassiri and Inderbir Gill.
The Ochsner Transplant Institute's kidney program has achieved ELITE Status through exceptional performance and superior results. The program demonstrates high-quality care and outstanding patient outcomes, earning recognition from INTERLINK COE Networks & Programs.
A recent study published in the Journal of Hepatology has shown that simultaneous bariatric surgery and liver transplant is safe and improves long-term health outcomes for severely obese patients. The combined approach resulted in sustained weight loss, reduced risk of type 2 diabetes, and lower risk of fatty liver disease recurrence.
Pediatric hearts fail due to acquired and genetic disorders or congenital heart disease, requiring mechanical circulatory support (MCS) devices. However, adult devices are often used off-label in pediatric patients, deterring innovation and limiting access to life-saving technology.
Researchers at ISHLT marked the 10-year anniversary of modern DCD heart donation, significantly increasing transplant volumes worldwide. Comparable outcomes have been achieved with DCD hearts compared to traditional DBD hearts, leading to a surge in DCD programs globally.
A new 'concierge' approach called the Kidney Transplant Fast Track enables more people to receive transplants and erases racial disparities. This streamlined process coordinates testing onsite and often performed by the transplant center, increasing patient suitability and reducing wait times.
Current methods like static cold storage and machine perfusion have limitations, with only 10% of global demand met. Researchers explore vitrification cryopreservation as a promising alternative to address toxicity issues and improve transplant survival rates.
The Vanderbilt Lung Transplant program performed a record-breaking 99 lung transplants in 2024, with two combined organ transplants. The program leads the nation in innovation in organ preservation and regeneration, and has the busiest program in the Southeast.
A new study shows that anti-obesity drugs, including GLP-1 agonists, are safe and effective in treating type 2 diabetes in kidney transplant recipients. The medications were found to reduce the risk of organ failure and death, but also increase the risk of diabetic retinopathy.
Researchers developed reprogrammed vascular endothelial cells that provide strong support for islets, allowing them to survive and reverse diabetes long-term. The study showed that mice transplanted with islet cells plus R-VECs regained normal blood glucose control after 20 weeks.
A study found that two liver graft preservation methods differ in their effect on gut microbiota composition and function following liver transplantation. The NMP cohort showed enrichment of beneficial gut taxa, while the static cold storage cohort depleted such taxa. Notable differences were observed between the two preservation methods.
Researchers have identified a key protein called Apex1 as a potential therapeutic target for stopping the immune system from attacking itself. By inhibiting this protein, harmful T cells that cause autoimmune diseases and allergies can be eliminated.
The Vanderbilt Transplant Center achieved a world record by performing 174 adult and pediatric heart transplants in 2024. The team's success was attributed to their multidisciplinary approach, innovative practices, and ability to accept high-risk patients from other centers.
Researchers have found that loosening the grip of engineered chimeric antigen receptor (CAR) Tregs improves their function and effectiveness in treating autoimmune diseases. By adjusting the affinity of the CAR, the study shows that Tregs can suppress immune responses while reducing pro-inflammatory consequences.
A new blood test reveals heart transplant patients at risk of rejection by analyzing DNA fragments in their blood. This non-invasive test is comparable to existing US tests and could save millions in public healthcare costs.
Researchers aim to advance eye transplantation through cutting-edge technologies and techniques, including cell-based therapies and device development. The six-year project, led by Kia Washington at the University of Colorado Anschutz Medical Campus, seeks to overcome current limitations in whole-eye transplant success rates.
Scientists at UCSF have developed engineered T cells that act as immune referees to soothe overreacting immune responses and mope up inflammatory molecules. These cells could improve treatment for organ transplants, type 1 diabetes and other autoimmune conditions by reducing the need for harsh immunosuppressant drugs.
The Increasing Organ Transplant Access (IOTA) Model aims to improve access to life-saving kidney transplants for patients with end-stage kidney disease while maintaining or improving the quality of care. The new rule will test performance-based upside or downside risk payments among selected kidney transplant hospitals.
The surgical team led by Stephanie H. Chang performed the groundbreaking procedure using da Vinci Xi robotic system at NYU Langone Transplant Institute. The successful transplant marks a significant milestone in lung transplantation surgery, offering hope to patients with chronic obstructive pulmonary disease (COPD) like Cheryl Mehrkar.
The Ochsner Transplant Institute collaborated with 25 US centers to conduct the first HIV-to-HIV kidney transplant study, showing comparable results between patients with and without HIV. The study's findings support the safe and effective use of HIV-positive donor organs in transplants.
Emerging technology allows long-term storage of human organs, addressing severe time constraints that limit organ viability. New governance and legal rules are needed to guide this application, including oversight from the FDA and ethics guidance on organ storage.
Researchers identified new signs of kidney transplant rejection, including microvascular inflammation, which predict increased risk of transplant failure. The study found that patients with these conditions are at higher risk of developing severe rejection or chronic kidney damage over time.
The world's first combined face and whole-eye transplantation successfully used personalized surgical cutting guides and a novel 'shortcut' to maintain blood flow. Innovative techniques ensured optimal blood flow to the retina, safeguarding the viability of the transplanted eye during the procedure.
A recent study by Children's Hospital Los Angeles showed that reprioritizing organ allocation led to better outcomes for children with PALF. The changes resulted in substantially decreased deaths on the pediatric waitlist, increased rates of liver transplant, and improved post-transplant outcomes.
Researchers found that heart transplant recipients from most deprived areas had a higher risk of dying within five years and experiencing organ failure compared to those from less deprived areas. Treatment at high-quality hospitals did not translate into better outcomes.
Researchers at IGTP have discovered a specific cellular pattern in regulatory B cells to monitor kidney transplant patients. This signature can help identify low-risk patients who may benefit from reduced immunosuppression and those at high risk who require closer monitoring.
Researchers develop a technique called nanowarming using magnetic nanoparticles and alternating magnetic fields to thaw frozen tissues rapidly and safely. This method enables the successful rewarming of animal tissues without causing tissue damage or toxicity.
The Northwestern University Transplant Access Program (AATAP) has supported nearly 300 patients, with over 50 receiving a kidney or liver transplant. The program focuses on the needs of Black Americans, addressing structural and institutional barriers to access.
Research reveals T cells regulate trained immunity, a process previously thought to be independent of the innate immune system. This discovery offers potential for new treatments in autoimmune disorders, cancer, and cardiovascular diseases.
The African American Transplant Access Program aims to mitigate disparities in solid organ transplantation, while a physician-created platform speeds clinical decision-making. NEJM Catalyst also explores quality and safety improvement through longitudinal care management for diabetes and hypertension.
Mayo Clinic's surgical team successfully performed the rare procedure, which included multiple organs, on a Massachusetts man with a rare form of laryngeal cancer. The landmark surgery, conducted as part of a clinical trial, marks a significant step towards making larynx transplantation available to a wider population.
A study published in Clinical Infectious Diseases found that regular booster doses of bivalent vaccines can maintain a person's ability to neutralize multiple SARS-CoV-2 strains, including XBB.1.5. This is especially important for immunocompromised groups, such as solid organ transplant recipients.
Researchers investigate organ donation practices after extracorporeal cardiopulmonary resuscitation (ECPR), finding delayed organ procurement intervals and lower lung graft survival rates in ECPR groups. The study suggests using ECPR may address the organ shortage crisis by increasing viable organs for transplantation.
Researchers at University of Cambridge uncover unified healer army of regulatory T cells that constantly move and repair damaged tissue. This discovery has implications for treating various diseases, including autoimmune disorders and infectious diseases.
A new study reveals specialized proteins can dramatically delay ice crystal formation in extreme cold, paving the way for impossible organ transplants. Cryogenic damage compromises cellular structures, leading to irreversible damage and organ failure.
A new study has identified disparities in liver transplant referral and evaluation that occur before waitlisting for patients with early-stage liver cancer. These disparities affect older, poorer, Black, and Medicaid beneficiaries, highlighting the need for targeted interventions to improve equity in access to liver transplantation.
A University of Houston researcher has made a breakthrough discovery about the development of the heart in the womb, revealing that a certain gene deletion can cause a common type of heart muscle disease called left ventricular non-compaction.
Scientists from Tokyo Medical and Dental University successfully generate autologous skin grafts by introducing mutations into mouse embryos, which then form sheets of epidermis containing hair follicles. These grafted skin patches survive up to 3 months and mimic mature epidermis structure.
The first pig-to-human kidney xenotransplants detected early signs of antibody-mediated rejection and showed human immune cells rapidly infiltrating the transplanted kidneys. However, the transplanted kidneys also began to repair themselves, with gene expression associated with cell proliferation observed within 24 hours.
Expert Insight provides a guide for transplant centers to monitor and address health disparities, including measures of socioeconomic status. The authors emphasize the need for transparency in the transplant process and equitable outcomes. By implementing these measures, transplant centers can improve patient access and quality of care.
A new implantable cardiac pump could revolutionize heart transplant care for children, allowing them to wait at home instead of in the hospital. The device performed well in a feasibility trial, with six out of seven children ultimately undergoing transplants and one child's heart recovering on its own.
A Mayo Clinic study found that laparoscopic sleeve gastrectomy can improve the health and eligibility of patients with advanced chronic kidney disease and obesity. The procedure reduced cardiovascular risks, including diabetes and hypertension, and improved access to kidney transplantation.
A combined mechanical heart pump and gene-edited pig kidney transplant has given new hope to a patient with heart and kidney failure. The surgery was performed in two stages, first implanting the heart pump and later transplanting the gene-edited pig kidney. This innovative approach has shown promise for patients who would otherwise no...
Researchers created a proteomics-based imaging mass cytometry marker panel to categorize immune cells at single-cell resolution, identifying unique signatures of active T-cell-mediated rejection. The study aims to find personalized immunosuppression therapies with fewer side effects.
Researchers have identified a subset of T-cells that acts like stem cells and continuously generates effector T-cells that attack transplanted organs. Targeting the transcription factor IRF4 may lead to innovative therapies for patients with chronic infections, cancers, autoimmune diseases and transplanted organs.
A collaborative study found that patients with end-stage renal disease who undergo weight loss surgery can experience significant improvements in BMI, hypertension, and diabetes management. This enhancement of overall health and transplant viability offers hope for previously ineligible patients.
A new study finds that Latinx children with unreliable access to food at age 4 are nearly four times more likely to develop fatty liver disease later. The researchers recommend earlier screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and ensuring public meal programs offer nutritious meals.